ZA9810371B - Th2 cell depletion; compositions; methods. - Google Patents

Th2 cell depletion; compositions; methods.

Info

Publication number
ZA9810371B
ZA9810371B ZA9810371A ZA9810371A ZA9810371B ZA 9810371 B ZA9810371 B ZA 9810371B ZA 9810371 A ZA9810371 A ZA 9810371A ZA 9810371 A ZA9810371 A ZA 9810371A ZA 9810371 B ZA9810371 B ZA 9810371B
Authority
ZA
South Africa
Prior art keywords
compositions
methods
cell depletion
depletion
cell
Prior art date
Application number
ZA9810371A
Other languages
English (en)
Inventor
Hortensia Soto-Trejo
Joseph A Hedrick
Albert Zlotnik
Monica Napolitano
Original Assignee
Schering Corp
Monica Napolitano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Monica Napolitano filed Critical Schering Corp
Publication of ZA9810371B publication Critical patent/ZA9810371B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9810371A 1997-11-13 1998-11-12 Th2 cell depletion; compositions; methods. ZA9810371B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6539297P 1997-11-13 1997-11-13

Publications (1)

Publication Number Publication Date
ZA9810371B true ZA9810371B (en) 1999-08-30

Family

ID=22062409

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810371A ZA9810371B (en) 1997-11-13 1998-11-12 Th2 cell depletion; compositions; methods.

Country Status (7)

Country Link
EP (1) EP1030865A2 (fr)
JP (1) JP2001523446A (fr)
AR (1) AR016681A1 (fr)
AU (1) AU1373099A (fr)
CA (1) CA2309761A1 (fr)
WO (1) WO1999025734A2 (fr)
ZA (1) ZA9810371B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416954B1 (en) * 1999-02-08 2002-07-09 Schering Corporation Modulating Th2 cell levels via vMIP-I/CCR8 interaction
WO2001058484A2 (fr) * 2000-02-10 2001-08-16 Schering Corporation Nouvelles utilisations des recepteurs ccr8 de mammiferes et reactifs associes
US6762341B2 (en) 2000-02-10 2004-07-13 Schering Corporation Uses of mammalian CCR8 receptors and related reagents
WO2003096020A2 (fr) * 2002-05-13 2003-11-20 Bayer Healthcare Ag Diagnostic et traitement de maladies liees au recepteur 8 des chimiokines (ccr8)
WO2007044756A2 (fr) * 2005-10-11 2007-04-19 Icos Corporation Anticorps monoclonaux reconnaissant le ccr8 humain
WO2014082993A2 (fr) * 2012-11-30 2014-06-05 Galapagos Nv Cibles moléculaires et composés, et procédés d'identification de ceux-ci, utiles dans la régulation à la baisse de la réponse th2
KR102623927B1 (ko) * 2016-05-16 2024-01-12 체크마브 에스.알.엘. 종양-침윤 조절 t 세포에서 선택적으로 조절 해제된 마커
SG11202106214YA (en) * 2018-12-27 2021-07-29 Shionogi & Co Novel anti-ccr8 antibody
EP4103285A2 (fr) 2020-02-14 2022-12-21 Jounce Therapeutics, Inc. Anticorps et protéines de fusion se liant à ccr8, et leurs utilisations
WO2023219147A1 (fr) * 2022-05-13 2023-11-16 塩野義製薬株式会社 Nouveaux anticorps anti-ccr8 pour la détection de ccr8

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364932A (en) * 1979-09-18 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same
DK0843557T3 (da) * 1995-07-21 2003-03-10 Inst Nat Sante Rech Med Fremgangsmåder til detektion, identifikation, isolation og selektiv mærkning og målsøgning af Th1-lymfocytter ved hjælp af LAG-3 protein
US6040426A (en) * 1996-06-05 2000-03-21 Bml, Inc. Human Th2 specific protein

Also Published As

Publication number Publication date
AR016681A1 (es) 2001-07-25
WO1999025734A2 (fr) 1999-05-27
EP1030865A2 (fr) 2000-08-30
AU1373099A (en) 1999-06-07
WO1999025734A3 (fr) 1999-07-15
JP2001523446A (ja) 2001-11-27
CA2309761A1 (fr) 1999-05-27

Similar Documents

Publication Publication Date Title
GB2323700B (en) Electrochemical cells
ZA984849B (en) Compositions.
ZA978256B (en) Electrolyte.
HK1025185A1 (en) Battery.
ZA965381B (en) Electrochemical cell.
ZA9811153B (en) An improved alkaline solid block composition.
ZA988142B (en) Cosmetic composition.
MXPA01002531A (es) Composicion cosmetica.
ZA971182B (en) Electrochemical cell.
EP0681339A3 (fr) Cellule électrochimique.
EP0662722A3 (fr) Disposition de cellules solaires.
AU7562898A (en) Photovoltaic cell
ZA9810371B (en) Th2 cell depletion; compositions; methods.
GB2348047B (en) Electrochemical cells
ZA9811502B (en) Novel composition.
ZA988586B (en) Truncated cellulase compositions.
ZA981893B (en) Chemical composition.
ZA200006118B (en) Novel composition.
ZA200000192B (en) Novel composition.
EP0930361A4 (fr) Compositions cellulaires
GB9919227D0 (en) Solar cell
ZA981739B (en) Composition.
AU6139298A (en) Photovoltaic cell
ZA991792B (en) Mouthwash composition.
ZA99925B (en) Composition.